Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;37(11):1349-1354.
doi: 10.1007/s40273-019-00842-0.

Transparency in Health Economic Modeling: Options, Issues and Potential Solutions

Affiliations
Free article

Transparency in Health Economic Modeling: Options, Issues and Potential Solutions

Eric Q Wu et al. Pharmacoeconomics. 2019 Nov.
Free article

Abstract

Economic models are increasingly being used by health economists to assess the value of health technologies and inform healthcare decision making. However, most published economic models represent a kind of black box, with known inputs and outputs but undisclosed internal calculations and assumptions. This lack of transparency makes the evaluation of the model results challenging, complicates comparisons between models, and limits the reproducibility of the models. Here, we aim to provide an overview of the possible steps that could be undertaken to make economic models more transparent and encourage model developers to share more detailed calculations and assumptions with their peers. Scenarios with different levels of transparency (i.e., how much information is disclosed) and reach of transparency (i.e., who has access to the disclosed information) are discussed, and five key concerns (copyrights, model misuse, confidential data, software, and time/resources) pertaining to model transparency are presented, along with possible solutions. While a shift toward open-source models is underway in health economics, as has happened before in other research fields, the challenges ahead should not be underestimated. Importantly, there is a pressing need to find an acceptable trade-off between the added value of model transparency and the time and resources needed to achieve such transparency. To this end, it will be crucial to set incentives at different stakeholder levels. Despite the many challenges, the many benefits of publicly sharing economic models make increased transparency a goal worth pursuing.

PubMed Disclaimer

References

    1. BMJ. 2007 Oct 13;335(7623):735 - PubMed
    1. N Engl J Med. 2017 Apr 27;376(17):1684-1687 - PubMed
    1. Pharmacoeconomics. 2019 Jun;37(6):829-843 - PubMed
    1. Pharmacoeconomics. 2017 Jan;35(1):125-128 - PubMed
    1. Med Care. 2017 Nov;55(11):915-917 - PubMed

MeSH terms

LinkOut - more resources